John S March

Summary

Affiliation: Duke University Medical Center
Country: USA

Publications

  1. ncbi The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    Arch Gen Psychiatry 64:1132-43. 2007
  2. ncbi The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks
    John March
    Department of Psychiatry, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 45:1393-403. 2006
  3. ncbi Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA
    Biol Psychiatry 61:344-7. 2007
  4. ncbi The case for practical clinical trials in psychiatry
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, 718 Rutherford St, Durham, NC 27705, USA
    Am J Psychiatry 162:836-46. 2005
  5. pmc Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Child Adolesc Psychopharmacol 19:519-27. 2009
  6. doi Clinical messages from the Treatment for Adolescents With Depression Study (TADS)
    John S March
    Division of Neurosciences Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Am J Psychiatry 166:1118-23. 2009
  7. pmc Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial
    Martin E Franklin
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    JAMA 306:1224-32. 2011
  8. ncbi Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Child Adolesc Psychopharmacol 16:91-102. 2006
  9. pmc A double-blind, placebo-controlled study of atomoxetine in young children with ADHD
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, 985581 Nebraska Medical Center, Omaha, NE 68198 5581, USA
    Pediatrics 127:e862-8. 2011
  10. pmc Dysfunctional attitudes scale perfectionism: a predictor and partial mediator of acute treatment outcome among clinically depressed adolescents
    RACHEL H JACOBS
    Department of Psychiatry, Northwestern University Feinberg School of Medicine, USA
    J Clin Child Adolesc Psychol 38:803-13. 2009

Detail Information

Publications65

  1. ncbi The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    Arch Gen Psychiatry 64:1132-43. 2007
    ..The Treatment for Adolescents With Depression Study evaluates the effectiveness of fluoxetine hydrochloride therapy, cognitive behavior therapy (CBT), and their combination in adolescents with major depressive disorder...
  2. ncbi The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks
    John March
    Department of Psychiatry, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 45:1393-403. 2006
    ..Taking benefit and risk into account, we conclude that the combination of FLX and CBT appears superior to either monotherapy as a treatment for moderate to severe major depressive disorder in adolescents...
  3. ncbi Tics moderate treatment outcome with sertraline but not cognitive-behavior therapy in pediatric obsessive-compulsive disorder
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA
    Biol Psychiatry 61:344-7. 2007
    ..The presence of a comorbid tic disorder may predict a poorer outcome in the acute treatment of pediatric obsessive-compulsive disorder (OCD)...
  4. ncbi The case for practical clinical trials in psychiatry
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, 718 Rutherford St, Durham, NC 27705, USA
    Am J Psychiatry 162:836-46. 2005
    ..The authors present the case for psychiatry's adoption of the practical clinical trials model, which is widely used in research in other areas of medicine...
  5. pmc Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Child Adolesc Psychopharmacol 19:519-27. 2009
    ..Because attention-deficit/hyperactivity disorder (ADHD) and major depressive disorder (MDD) frequently co-exist, we examined whether ADHD moderated these outcomes in TADS...
  6. doi Clinical messages from the Treatment for Adolescents With Depression Study (TADS)
    John S March
    Division of Neurosciences Medicine, Duke Clinical Research Institute, Duke University Medical Center, Durham, NC 27705, USA
    Am J Psychiatry 166:1118-23. 2009
    ..The purpose of this report was to summarize the key clinical messages from the Treatment for Adolescents with Depression Study (TADS)...
  7. pmc Cognitive behavior therapy augmentation of pharmacotherapy in pediatric obsessive-compulsive disorder: the Pediatric OCD Treatment Study II (POTS II) randomized controlled trial
    Martin E Franklin
    Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
    JAMA 306:1224-32. 2011
    ....
  8. ncbi Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, Duke University Medical Center, Durham, North Carolina 27710, USA
    J Child Adolesc Psychopharmacol 16:91-102. 2006
    ..The aim of this study was to examine the balance between the benefits of treatment and the risk of suicidality in children and adolescents in multicenter, randomized, controlled trials of sertraline versus placebo...
  9. pmc A double-blind, placebo-controlled study of atomoxetine in young children with ADHD
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, 985581 Nebraska Medical Center, Omaha, NE 68198 5581, USA
    Pediatrics 127:e862-8. 2011
    ..To evaluate the efficacy and tolerability of atomoxetine for the treatment of attention-deficit/hyperactivity disorder (ADHD) in 5- and 6-year-old children...
  10. pmc Dysfunctional attitudes scale perfectionism: a predictor and partial mediator of acute treatment outcome among clinically depressed adolescents
    RACHEL H JACOBS
    Department of Psychiatry, Northwestern University Feinberg School of Medicine, USA
    J Clin Child Adolesc Psychol 38:803-13. 2009
    ..In the case of suicidality, DAS perfectionism impeded improvement. Treatment outcomes were partially mediated by the change in DAS perfectionism across the 12-week period...
  11. pmc The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned
    Mark Shapiro
    Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina, USA
    Child Adolesc Psychiatry Ment Health 3:12. 2009
    ....
  12. ncbi The pediatric obsessive-compulsive disorder treatment study: rationale, design, and methods
    Martin Franklin
    Center for the Treatment and Study of Anxiety, Department of Psychiatry, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    J Child Adolesc Psychopharmacol 13:S39-51. 2003
    ..All patients, regardless of responder status, return for all scheduled assessments. This report describes the design of the trial, the rationale for the design choices made, and the methods used to carry out the trial...
  13. ncbi A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder
    John S March
    Department of Psychiatry, Duke University Medical Center, Durham, North Carolina 27710, USA
    Biol Psychiatry 62:1149-54. 2007
    ..Social anxiety disorder, which occurs in 2% to 5% of children and adolescents, is associated with significant distress and functional impairment...
  14. ncbi AACAP 2005 Research Forum: speeding the adoption of evidence-based practice in pediatric psychiatry
    John S March
    Department of Psychiatry, Duke University Medical Center, Child and Family Study Center, 718 Rutherford Street, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 46:1098-110. 2007
    ....
  15. ncbi Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review
    Scott N Compton
    Pediatric Psychiatry, Duke University Medical Center, DUMC Box 3527, Durham, NC 27710, USA
    Pediatr Ann 36:586-90, 592, 594-8. 2007
  16. ncbi Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review
    Scott N Compton
    Department of Psychiatry and Behavioral Psychology, Duke University Medical Center, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 43:930-59. 2004
    ..To review the literature on the cognitive-behavioral treatment of children and adolescents with anxiety and depressive disorders within the conceptual framework of evidence-based medicine...
  17. ncbi Pharmacological management of treatment-resistant pediatric depression
    Christopher J Kratochvil
    Department of Psychiatry, University of Nebraska Medical Center, Omaha, NE 68195 5581, USA
    J Am Acad Child Adolesc Psychiatry 44:198-200. 2005
  18. ncbi Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial
    John March
    Duke Clinical Research Institute, Department of Psychiatry, Duke University Medical Center, Durham, NC 27710, USA
    JAMA 292:807-20. 2004
    ..Initial treatment of major depressive disorder in adolescents may include cognitive-behavioral therapy (CBT) or a selective serotonin reuptake inhibitor (SSRI). However, little is known about their relative or combined effectiveness...
  19. ncbi AACAP 2002 research forum: placebo and alternatives to placebo in randomized controlled trials in pediatric psychopharmacology
    John March
    Duke University Medical Center, Durham, NC 27705, USA
    J Am Acad Child Adolesc Psychiatry 43:1046-56. 2004
    ..The purpose was to identify challenges and their solutions regarding the use of placebo in randomized controlled trials in pediatric psychopharmacology...
  20. ncbi Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder
    Karen C Wells
    Department of Psychiatry, Duke University Medical Center, Durham, NC, USA
    J Consult Clin Psychol 74:649-57. 2006
    ..The authors discuss the importance of changes in parenting behavior for families of children with ADHD and the need for reliable and objective measures in evaluating treatment outcome...
  21. pmc Recovery and recurrence following treatment for adolescent major depression
    John Curry
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA
    Arch Gen Psychiatry 68:263-9. 2011
    ..Major depressive disorder in adolescents is common and impairing. Efficacious treatments have been developed, but little is known about longer-term outcomes, including recurrence...
  22. ncbi Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS)
    John Curry
    Duke Child and Family Study Center, NC 27705, USA
    J Am Acad Child Adolesc Psychiatry 45:1427-39. 2006
    ....
  23. doi The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up
    John March
    Department of Psychiatry and Behavioral Sciences and the Duke Clinical Research Institute at Duke University Medical Center, Durham, NC 27705, USA
    Am J Psychiatry 166:1141-9. 2009
    ..The authors report effectiveness outcomes across a 1-year naturalistic follow-up period...
  24. ncbi Assessing medication effects in the MTA study using neuropsychological outcomes
    Jeffery N Epstein
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27710, USA
    J Child Psychol Psychiatry 47:446-56. 2006
    ....
  25. doi Looking to the future of research in pediatric anxiety disorders
    John S March
    Division of Neurosciences Medicine, Duke Clinical Research Institute, Duke University Medical Center, 2400 Pratt Street, Durham, NC 27705, USA
    Depress Anxiety 28:88-98. 2011
    ....
  26. ncbi Delinquent behavior and emerging substance use in the MTA at 36 months: prevalence, course, and treatment effects
    Brooke S G Molina
    Department of Psychiatry, University of Pittsburgh School of Medicine, 3811 O Hara Street, Pittsburgh, PA 15213, USA
    J Am Acad Child Adolesc Psychiatry 46:1028-40. 2007
    ....
  27. ncbi Using and teaching evidence-based medicine: the Duke University child and adolescent psychiatry model
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke Child and Family Study Center, Duke University Medical Center, 718 Rutherford Street DUMC 3527, Durham, NC 27710, USA
    Child Adolesc Psychiatr Clin N Am 14:273-96, viii-ix. 2005
    ....
  28. ncbi Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD
    L Eugene Arnold
    Department of Psychiatry, Ohio State University, USA
    J Consult Clin Psychol 71:713-27. 2003
    ..Treatment for lower socioeconomic status minority children, especially if comorbid, should combine medication and behavioral treatment...
  29. doi The future of psychotherapy for mentally ill children and adolescents
    John S March
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC 27705, USA
    J Child Psychol Psychiatry 50:170-9. 2009
    ..This simple fact has enormous implications for the nature and organization of psychotherapy for mentally ill children, adolescents and adults...
  30. ncbi An evidence-based medicine approach to combined treatment for ADHD in children and adolescents
    Douglas G Kondo
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27705, USA
    Psychopharmacol Bull 37:7-23. 2003
    ....
  31. ncbi Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder
    Scott H Kollins
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA
    Biol Psychiatry 62:951-3. 2007
  32. ncbi Child and adolescent psychopharmacology in the new millennium: a workshop for academia, industry, and government
    Joseph DeVeaugh-Geiss
    Duke Clinical Research Institute, Durham, NC 27715, USA
    J Am Acad Child Adolesc Psychiatry 45:261-70. 2006
    ..To give academic researchers, government officials, and industry scientists an opportunity to assess the state of pediatric psychopharmacology and identify challenges facing professionals in the field...
  33. ncbi The Child and Adolescent Psychiatry Trials Network (CAPTN)
    John S March
    Department of Psychiatry and Behavioral Sciences and the Duke Clinical Research Institute at Duke University Medical Center, Durham, NC 27710, USA
    J Am Acad Child Adolesc Psychiatry 43:515-8. 2004
    ..The current generation of clinical trials in pediatric psychiatry often fails to maximize clinical utility for practicing clinicians, thereby diluting its impact...
  34. ncbi Is parental report of upper respiratory infection at the onset of obsessive-compulsive disorder suggestive of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection?
    Lisa Giulino
    Child and Family Study Center, Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina 27705, USA
    J Child Adolesc Psychopharmacol 12:157-64. 2002
    ..Additional research is required to define the boundaries of PANDAS and to develop psychometrically reliable and valid diagnostic strategies...
  35. ncbi Development and natural history of mood disorders
    E Jane Costello
    Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, North Carolina, USA
    Biol Psychiatry 52:529-42. 2002
    ..A diverse program of multidisciplinary research is recommended to reduce the burden on children and families affected with these conditions...
  36. ncbi Response to methylphenidate in children with attention deficit hyperactivity disorder and manic symptoms in the multimodal treatment study of children with attention deficit hyperactivity disorder titration trial
    Cathryn A Galanter
    Columbia University New York State Psychiatric Institute, New York, New York 10032, USA
    J Child Adolesc Psychopharmacol 13:123-36. 2003
    ..Recent reports raise concern that children with attention deficit hyperactivity disorder (ADHD) and some manic symptoms may worsen with stimulant treatment. This study examines the response to methylphenidate in such children...
  37. ncbi Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS)
    Benedetto Vitiello
    Division of Services and Intervention Research, National Institute of Mental Health, Bethesda, MD 20892 9633, USA
    J Am Acad Child Adolesc Psychiatry 46:1642-50. 2007
    ..We examined the extent to which parents and adolescents participating in the Treatment for Adolescents With Depression Study (TADS) understood key aspects of the study...
  38. pmc Achievement and maintenance of sustained response during the Treatment for Adolescents With Depression Study continuation and maintenance therapy
    Paul Rohde
    Oregon Research Institute, 1715 Franklin Blvd, Eugene, OR 97403 1983, USA
    Arch Gen Psychiatry 65:447-55. 2008
    ..Treatment consisted of 3 stages: (1) acute (12 weeks), (2) continuation (6 weeks), and (3) maintenance (18 weeks)...
  39. ncbi Review of safety assessment methods used in pediatric psychopharmacology
    Laurence L Greenhill
    New York State Psychiatric Institute Columbia University, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:627-33. 2003
    ..Elicitation is an essential and critical step in ascertaining adverse events (AEs). This report reviews elicitation methods used in published clinical trials of psychopharmacological agents in children...
  40. ncbi Cost-effectiveness of treatments for adolescent depression: results from TADS
    Marisa Elena Domino
    Department of Health Policy and Administration, School of Public Health, University of North Carolina at Chapel Hill, 1104G McGavran Greenberg Hall, CB 7411, Chapel Hill, NC 27599, USA
    Am J Psychiatry 165:588-96. 2008
    ..Treatment costs are a relevant concern given the competing demands on family and health care budgets. The authors evaluated the cost-effectiveness of three active treatments among adolescents with major depressive disorder...
  41. pmc Authors of TADS study reply to letter raising concerns
    John S March
    BMJ 330:730-1. 2005
  42. ncbi Cognitive-behavioral family treatment of childhood obsessive-compulsive disorder: a controlled trial
    Paula Barrett
    School of Applied Psychology, Griffith University, Australia
    J Am Acad Child Adolesc Psychiatry 43:46-62. 2004
    ..To evaluate the relative efficacy of (1) individual cognitive-behavioral family-based therapy (CBFT); (2) group CBFT; and (3) a waitlist control group in the treatment of childhood obsessive-compulsive disorder (OCD)...
  43. ncbi Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA
    James M Swanson
    Department of Pediatrics, University of California, Irvine 92612, USA
    J Abnorm Child Psychol 30:327-32. 2002
    ..Finally, we invite others to use the large and rich data set that will soon be available in the public domain, to perform secondary analyses to mine the meaning of the MTA and to evaluate theories of ADHD and response to treatments...
  44. ncbi Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution
    Howard Abikoff
    Child and Adolescent Psychiatry, NYU Child Study Center, NYU School of Medicine, NY 10016, USA
    J Am Acad Child Adolesc Psychiatry 41:498-504. 2002
    ..Although the manual-based guidelines are especially applicable to multisite RCTs, many of the procedures in the ASAP Manual can apply to any treatment study in children...
  45. ncbi Socioeconomic status as a moderator of ADHD treatment outcomes
    Ricardo Rieppi
    Department of Psychology, St Johns University, Jamaica, NY 11439, USA
    J Am Acad Child Adolesc Psychiatry 41:269-77. 2002
    ....
  46. ncbi Improving attention-deficit/hyperactivity disorder treatment outcomes through use of a collaborative consultation treatment service by community-based pediatricians: a cluster randomized trial
    Jeffery N Epstein
    Cincinnati Children s Hospital Medical Center, Cincinnati, OH 45206, USA
    Arch Pediatr Adolesc Med 161:835-40. 2007
    ..To test whether adoption of a collaborative consultative service model results in improved patient outcomes...
  47. ncbi Empirically derived subtypes of adolescent depression: latent profile analysis of co-occurring symptoms in the Treatment for Adolescents with Depression Study (TADS)
    Keith C Herman
    Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21287 3325, USA
    J Consult Clin Psychol 75:716-28. 2007
    ..The discussion focuses on understanding subtypes and comorbidity in adolescent depression as well as the implications for treatment and for prevention...
  48. ncbi Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures
    L Eugene Arnold
    The Ohio State University, Columbus, Ohio, USA
    J Abnorm Child Psychol 32:39-51. 2004
    ....
  49. ncbi Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder
    Betsy Hoza
    Department of Psychological Sciences, Purdue University, West Lafayette, IN 47907 2081, USA
    J Clin Child Adolesc Psychol 34:74-86. 2005
    ..Results indicated that children from all groups remained significantly impaired in their peer relationships...
  50. ncbi Factors associated with recruitment and screening in the Treatment for Adolescents With Depression Study (TADS)
    Diane E May
    University of Nebraska Medical Center, Omaha, NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 46:801-10. 2007
    ..To examine factors associated with eligibility and randomization and consider the efficiency of recruitment methods...
  51. ncbi Selective serotonin reuptake inhibitors in pediatric depression: is the balance between benefits and risks favorable?
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska 68198, USA
    J Child Adolesc Psychopharmacol 16:11-24. 2006
    ..The authors have concluded that SSRIs -- in particular, fluoxetine -- do have a role in the treatment of pediatric depression...
  52. ncbi 3-year follow-up of the NIMH MTA study
    Peter S Jensen
    Center for the Advancement of Children s Mental Health, Unit 78, Columbia University NYSPI, 1051 Riverside Drive, New York, NY 10027, USA
    J Am Acad Child Adolesc Psychiatry 46:989-1002. 2007
    ..This report examines 36-month outcomes, 2 years after treatment by the study ended...
  53. ncbi Comparative efficacy of cognitive behavioral therapy, fluoxetine, and their combination in depressed adolescents: initial lessons from the treatment for adolescents with depression study
    Sanjeev Pathak
    University of Cincinnati College of Medicine, Children s Hospital Medical Center, MLC D 3014, 3333 Burnet Avenue, Cincinnati, OH 45229, USA
    Curr Psychiatry Rep 7:429-34. 2005
    ..Moreover, the study results confirm that fluoxetine alone is effective in the treatment of depressed adolescents...
  54. ncbi Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses
    James M Swanson
    UCI Child Development Center, 19722 MacArthur Blvd, Irvine, CA 92612, USA
    J Am Acad Child Adolesc Psychiatry 46:1003-14. 2007
    ....
  55. ncbi Effects of stimulant medication on growth rates across 3 years in the MTA follow-up
    James M Swanson
    UCI Child Development Center, 19722 MacArthur Blvd, Irvine, CA 92612, USA
    J Am Acad Child Adolesc Psychiatry 46:1015-27. 2007
    ..To evaluate the hypothesis of stimulant medication effect on physical growth in the follow-up phase of the Multimodal Treatment Study of Children With ADHD...
  56. ncbi Developing methodologies for monitoring long-term safety of psychotropic medications in children: report on the NIMH conference, September 25, 2000
    Laurence L Greenhill
    New York State Psychiatric Institute, New York 10032, USA
    J Am Acad Child Adolesc Psychiatry 42:651-5. 2003
    ..To improve the methods for long-term assessment of drug-associated side effects and advance knowledge of the safety profile of psychotropic medications in children and adolescents...
  57. ncbi The role of stimulants in the treatment of preschool children with attention-deficit hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska 68198 5581, USA
    CNS Drugs 18:957-66. 2004
    ....
  58. ncbi Observed classroom behavior of children with ADHD: relationship to gender and comorbidity
    Howard B Abikoff
    New York University School of Medicine, New York, USA
    J Abnorm Child Psychol 30:349-59. 2002
    ....
  59. ncbi Pharmacotherapy of childhood anxiety disorders
    Christopher J Kratochvil
    Department of Child and Adolescent Psychiatry, University of Nebraska Medical Center, 44th and Emile, Omaha, NE 68198, USA
    Curr Psychiatry Rep 4:264-9. 2002
    ..This article will review significant pharmacologic studies published in the prior year, and the role of pharmacotherapy in the treatment of pediatric anxiety disorders...
  60. ncbi Which treatment for whom for ADHD? Moderators of treatment response in the MTA
    Elizabeth B Owens
    Institute of Human Development, University of California, Berkeley 94720 1690, USA
    J Consult Clin Psychol 71:540-52. 2003
    ..No predictors or moderators emerged for behavioral and community comparison treatments. The authors discuss conceptual and clinical implications of research on treatment moderators...
  61. ncbi A manual-based intervention to address clinical crises and retain patients in the Treatment of Adolescents With Depression Study (TADS)
    Diane E May
    University of Nebraska Medical Center, Omaha, NE 68198 5581, USA
    J Am Acad Child Adolesc Psychiatry 46:573-81. 2007
    ..To describe a manual-based intervention to address clinical crises and retain participants in the Treatment for Adolescents With Depression Study (TADS)...
  62. ncbi A pilot study of atomoxetine in young children with attention-deficit/hyperactivity disorder
    Christopher J Kratochvil
    University of Nebraska Medical Center, Omaha, Nebraska, USA
    J Child Adolesc Psychopharmacol 17:175-85. 2007
    ..The purpose of this study was to assess the effectiveness and tolerability of atomoxetine during acute treatment of attention-deficit/hyperactivity disorder (ADHD) in 5 and 6 year olds...
  63. ncbi Clinical practice guidelines
    Peter Szatmari
    J Am Acad Child Adolesc Psychiatry 46:939-40; discussion 940-2. 2007
  64. ncbi Behavioral avoidance test for childhood obsessive-compulsive disorder: a home-based observation
    Paula Barrett
    School of Applied Psychology, Griffith University, Mount Gravatt, Queensland, 4122, Australia
    Am J Psychother 57:80-100. 2003
    ..The results of the current study strongly support the sensitivity of a standardized BAT in assessing treatment-related changes in children and adolescents with OCD. Implications and future directions for research are discussed...
  65. ncbi How can we improve the assessment of safety in child and adolescent psychopharmacology?
    Benedetto Vitiello
    Division of Services and Intervention Research, NIMH, Bethesda, MD 20982 9633, USA
    J Am Acad Child Adolesc Psychiatry 42:634-41. 2003
    ..To identify approaches to improving methods for assessing tolerability and safety of psychotropic medications in children and adolescents...